Lumida
/PRAX
⌘K
Praxis Precision Medicines Inc

Praxis Precision Medicines Inc

PRAX
$334.58USD-1.18%-3.99 today

MARKET CAP

9.3B

P/E (TTM)

FWD P/E

DAY RANGE

$334 – $348

52W RANGE

$37
$393

AI Summary

Stalk
Sell NowMedium

PRAX has broken multi-week support around $335 (Support Failure) and is trading below its 9/20 EMAs and the 50-day SMA, confirming bearish momentum. The primary Support Failure pattern signals sellers overwhelming buyers, with further downside likely toward the rising 200-day SMA near $311. Short-term momentum is negative, as price rejects resistance at declining EMAs. Medium-term bias remains bearish in Stage 3 distribution. While RSI is oversold, the structural context favors selling now into any rally under EMA resistance. The long-term uptrend above the 200-day SMA remains intact but is currently overshadowed by distribution dynamics.

  • $1.4B in cash and equivalents at Q1 2026 funds R&D and launch through 2028
  • NDA for ulexacultamide and relutrigine accepted; combined peak sales >$10B
  • Q1 2026 operating expenses surged 100% YoY to $106M, straining cash burn
Full analysis →

Buying

6

institutions

Selling

10

institutions

New Positions

1

this quarter

Filing Period

Q1 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
JH

Janus Henderson Group Plc

Q1 2026

BUY3.54 M1.14 B+303.72 K+19.5%0.28%
BI

Blackrock, Inc.

Q2 2026

SELL2.29 M767.53 M+-32.34 K+2.5%0.01%
PA

Perceptive Advisors LLC

Q2 2026

SELL2.04 M681.63 M+-2.04 M-48.0%10.26%
WP

Woodline Partners LP

Q2 2026

SELL200.01 K66.96 M+-200.01 K-48.0%0.21%
TR

T. Rowe Price Investment Management, Inc.

Q2 2026

SELL160.48 K53.73 M+-14.76 K-4.8%0.04%
AC

Adar1 Capital Management, LLC

Q2 2026

BUY74.25 K24.86 M+72.75 K+5043.8%1.15%
AC

Aqr Capital Management LLC

Q2 2026

SELL58.45 K19.57 M+-210.00+3.5%0.01%
CA

Citadel Advisors LLC

Q2 2026

SELL50.33 K16.85 M+-26.17 K-31.6%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

SELL44.09 K15.81 M+-36.09 K-28.7%0.00%
CP

California Public Employees Retirement System

Q2 2026

BUY45.37 K15.19 M+3.21 K+11.8%0.01%
MG

Man Group Plc

Q2 2026

BUY21.16 K7.09 M+17.99 K+593.1%0.01%
BA

Balyasny Asset Management L.P.

Q2 2026

BUYNEW1.88 K629.40 K+1.88 K+0.0%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

BUY1.48 K494.82 K+506.00+58.0%0.00%
MM

Millennium Management LLC

Q2 2026

SELL995.00333.12 K+-9.64 K-90.3%0.00%
RC

Ra Capital Management, L.P.

Q2 2026

SELL0.000.00+-373.79 K-100.0%0.00%
EP

Eversept Partners, LP

Q2 2026

SELL0.000.00+-14.80 K-100.0%0.00%